๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2024-09-04

End-Tidal Oxygen for Intubation in the Emergency Department (NCT06578468)

Preoxygenation Using End-Tidal Oxygen for Rapid Sequence Intubation in the Emergency Department (The PREOXED Trial) - a Multicentre Stepped Wedge Cluster Randomised Control Trial

๐ŸŸข Recruiting Observational / Diagnostic โš™๏ธ Medical Device Protocol Sponsor: Sydney Local Health District

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

Rapid Sequence Intubation (RSI) is a high-risk procedure in the emergency department (ED). Patients are routinely preoxygenated (given supplemental oxygen) prior to RSI to prevent hypoxia during intubation. For many years anaesthetists have used end-tidal oxygen (ETO2) levels to guide the effectiveness of preoxygenation prior to intubation. The ETO2 gives an objective measurement of preoxygenation efficacy. This is currently not available in most EDs. This trial evaluates the use of ETO2 on the rate of hypoxia during intubation for patients in the ED.

Who can join: Review the eligibility criteria below.

Location: Hennepin Medical Center โ€” Minneapolis, Minnesota

Age range: 18 Years

๐Ÿงช Interventions in This Study

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (9 Sites)

  • Hennepin Medical Center โ€” Minneapolis, Minnesota
  • University of New Mexico Medical Center โ€” Albuquerque, New Mexico
  • Lincoln Medical Center โ€” The Bronx, New York
  • Westmead Hospital โ€” Sydney, New South Wales
  • Royal Prince Alfred Hospital โ€” Sydney, New South Wales
  • Liverpool Hospital โ€” Sydney, New South Wales
  • Northern Beaches Hospital โ€” Sydney, New South Wales
  • Royal North Shore Hospital โ€” Sydney, New South Wales
  • The Alfred Hospital โ€” Melbourne, Victoria

๐Ÿ“ž Contact the Study Coordinator

Phone: +61410188680

Email: matthew.oliver@health.nsw.gov.au

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Critical Illness clinical trials

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—